1. Clinical Overview
Piperacillin and Tazobactam is a fixed-dose combination injectable antibacterial agent. Piperacillin is an extended-spectrum penicillin (ureidopenicillin) with activity against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria. Tazobactam is a beta-lactamase inhibitor (a penicillanic acid sulfone derivative) that protects piperacillin from degradation by many beta-lactamase enzymes, thereby extending its spectrum of activity to include many beta-lactamase-producing strains that are otherwise resistant. It is a cornerstone therapy for moderate to severe hospital-acquired infections in the Indian setting.
| Onset | Duration | Bioavailability |
|---|---|---|
| Rapid; therapeutic serum concentrations are achieved immediately after completion of an intravenous infusion. | Approximately 4-6 hours, necessitating dosing every 6-8 hours for most indications. | Not applicable (administered intravenously or intramuscularly). Bioavailability is considered 100% for IV route. |
2. Mechanism of Action
Piperacillin binds to and inhibits penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. This inhibition interferes with the final transpeptidation step of peptidoglycan synthesis, a critical component of the bacterial cell wall, leading to cell lysis and death. Tazobactam has very weak antibacterial activity itself but is an irreversible, competitive inhibitor of many beta-lactamase enzymes (including TEM, SHV, and some OXA types) produced by bacteria. By binding to these enzymes, it prevents the hydrolysis and inactivation of piperacillin, thereby restoring and extending its bactericidal spectrum.
3. Indications & Uses
- Intra-abdominal infections (e.g., appendicitis, peritonitis)
- Nosocomial pneumonia (including ventilator-associated pneumonia)
- Complicated skin and skin structure infections
- Complicated urinary tract infections (including pyelonephritis)
- Pelvic inflammatory disease
- Septicemia
4. Dosage & Administration
Adult Dosage: 3.375g (3g piperacillin + 0.375g tazobactam) IV every 6 hours OR 4.5g (4g piperacillin + 0.5g tazobactam) IV every 8 hours for most serious infections. For nosocomial pneumonia, empirical dosing of 4.5g every 6 hours is recommended.
Administration: For IV use only. Reconstitute powder with a compatible diluent (e.g., 0.9% Sodium Chloride, 5% Dextrose, Sterile Water for Injection). Shake well until dissolved. Further dilute to a final volume of 50-150 mL. Administer by intravenous infusion over 30 minutes. IM administration is possible but less common and painful; use only when IV access is not feasible. Do not mix with aminoglycosides in the same IV line/bag due to physical incompatibility.
5. Side Effects
Common side effects may include:
- Diarrhea (including antibiotic-associated diarrhea)
- Headache
- Nausea and vomiting
- Insomnia
- Constipation
- Rash (maculopapular)
- Pain/Phlebitis at injection site
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Probenecid | Inhibits renal tubular secretion of piperacillin, increasing and prolonging serum concentrations of both components. | Moderate |
| Aminoglycosides (Gentamicin, Amikacin) | Synergistic antibacterial effect against some organisms (e.g., Pseudomonas). However, physical incompatibility when mixed in same IV line; piperacillin may inactivate aminoglycosides in vitro. | Moderate |
| Methotrexate | Piperacillin may reduce renal clearance of methotrexate, leading to increased methotrexate levels and toxicity. | Major |
| Vecuronium, other neuromuscular blockers | May prolong neuromuscular blockade. | Moderate |
| Oral Contraceptives | Potential reduction in efficacy due to altered gut flora; advise use of non-hormonal contraception. | Moderate |
| Anticoagulants (Heparin, Warfarin) | Increased risk of bleeding due to effects on platelet aggregation and vitamin K-dependent clotting factors. | Major |
| Live Bacterial Vaccines (e.g., Typhoid, BCG) | Antibiotics may diminish therapeutic effect of live vaccines. | Moderate |
7. Patient Counselling
- Complete the full prescribed course of therapy, even if you feel better.
- Inform all your healthcare providers (doctors, dentists) that you are on this injection.
- Do not skip doses. If you miss a scheduled dose in the hospital, inform the nursing staff immediately.
- Do not take any antidiarrheal medication for loose stools without consulting your doctor, as it may be a sign of C. difficile infection.
8. Toxicology & Storage
Overdose: Neurological manifestations including seizures, encephalopathy, and neuromuscular excitability or hyperreflexia. Electrolyte disturbances (hypernatremia, hypokalemia). Nausea, vomiting, and diarrhea may occur.
Storage: Store unopened vials/powder at controlled room temperature (not exceeding 25°C), protected from light and moisture. Keep out of reach of children. After reconstitution and dilution: The solution is stable for 24 hours at room temperature and up to 7 days when refrigerated at 2-8°C in compatible diluents. Do not freeze. Always inspect the solution for particulate matter and discoloration before administration.